These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16207558)

  • 1. Impact of heparin neutralization by protamine on restenosis after coronary stent implantation.
    Kaneda H; Suzuki J; Hosokawa G; Tanaka S; Hiroe Y; Saito S
    Int J Cardiol; 2005 Oct; 105(1):111-2. PubMed ID: 16207558
    [No Abstract]   [Full Text] [Related]  

  • 2. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
    Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
    J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.
    Bartorelli AL; Tamburino C; Trabattoni D; Galassi A; Serdoz R; Sheiban I; Piovaccari G; Zimarino M; Benassi A; Di Mario C; Sangiorgio P; Chierchia S; Reimers B;
    Am J Cardiol; 2007 Apr; 99(8):1062-6. PubMed ID: 17437728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observance of antiplatelet therapy after stent implantation in patients under chronic oral anticoagulant treatment.
    Valencia J; Mainar V; Bordes P; Pineda J; Gómez S; Sogorb F
    J Interv Cardiol; 2008 Jun; 21(3):218-24. PubMed ID: 18422520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous treatment of a giant coronary aneurysm using a Symbiot stent.
    Roy P; Ajani AE; Warren R
    Cardiovasc Revasc Med; 2005; 6(2):73-4. PubMed ID: 16263363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation.
    Pan M; Suárez de Lezo J; Medina A; Romero M; Hernández E; Segura J; Melian F; Wangüemert F; Landin M; Benítez F; Amat M; Velasco F; Torres A
    Am J Cardiol; 1997 Nov; 80(10):1336-8. PubMed ID: 9388109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of bifurcation lesions using dedicated bifurcation stents versus classic bare-metal stents. Randomized, controlled trial with 12-month angiographic follow up.
    Cervinka P; Bystron M; Spacek R; Kvasnak M; Adhikari S; Jakabcin J
    J Invasive Cardiol; 2008 Oct; 20(10):516-20. PubMed ID: 18829995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in post stenting medication protocol.
    Morice MC
    J Invasive Cardiol; 1995; 7 Suppl A():32A-35A. PubMed ID: 10155114
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study.
    Biondi-Zoccai GG; Agostoni P; Sangiorgi GM; Iakovou I; Antoniucci D; Grube E; Tamburino C; Di Mario C; Reimers B; Michev I; Goktekin O; Airoldi F; Chieffo A; Cosgrave J; Tassanawiwat W; Colombo A;
    Int J Cardiol; 2006 Apr; 108(3):406-7. PubMed ID: 16520130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
    Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; SanMartín M; Gómez-Hospital JA; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
    Eur Heart J; 2007 Aug; 28(16):1946-52. PubMed ID: 17562666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Standard pharmacological therapy associated with percutaneous coronary interventions in patients with stable angina].
    Karcz M; Ruzyłło W
    Kardiol Pol; 2004 Nov; 61(11):480-2. PubMed ID: 15883598
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention.
    Patel AA; White CM; Coleman CI
    Conn Med; 2007 Feb; 71(2):93-5. PubMed ID: 17393902
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
    Weisz G; Moses JW; Teirstein PS; Holmes DR; Raizner AE; Satler LF; Mishkel G; Wilensky RL; Wang P; Kuntz RE; Popma JJ; Leon MB
    Am J Cardiol; 2007 Apr; 99(8):1044-50. PubMed ID: 17437725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary stenting and inflammation.
    Gaspardone A; Versaci F
    Am J Cardiol; 2005 Dec; 96(12A):65L-70L. PubMed ID: 16399095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
    Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
    Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restenosis developing over one year after implantation with a sirolimus-eluting stent: two case reports.
    Katayama T; Ogata N; Tsuruya Y
    J Cardiol; 2007 Jun; 49(6):345-52. PubMed ID: 17633572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary stent thrombosis: insights from the porcine coronary stent model.
    Lowe HC; Kumar RK; Chesterman CN; Fahmy RG; Khachigian LM
    Thromb Haemost; 2001 Sep; 86(3):937-8. PubMed ID: 11583335
    [No Abstract]   [Full Text] [Related]  

  • 19. A Palmaz-Schatz stent was partially resected by directional coronary atherectomy device to treat a stent-jailed side branch.
    Urasawa K; Oyama N; Sakai H
    J Invasive Cardiol; 2004 Oct; 16(10):606-7. PubMed ID: 15505364
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.
    Karjalainen PP; Porela P; Ylitalo A; Vikman S; Nyman K; Vaittinen MA; Airaksinen TJ; Niemelä M; Vahlberg T; Airaksinen KE
    Eur Heart J; 2007 Mar; 28(6):726-32. PubMed ID: 17267456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.